-
Effect of Aspiration Therapy on Obesity-Related Comorbidities: Systematic Review and Meta-Analysis
-
Pichamol Jirapinyo, Diogo T. H. de Moura, Laura C. Horton, Christopher C. Thompson
-
Clin Endosc 2020;53(6):686-697. Published online February 28, 2020
-
DOI: https://doi.org/10.5946/ce.2019.181
-
-
 Abstract
 PDF PubReader ePub
- Background
/Aims: Aspiration therapy (AT) involves endoscopic placement of a gastrostomy tube with an external device that allows patients to drain 30% of ingested calories after meals. Its efficacy for inducing weight loss has been shown. This study aimed to assess the effect of AT on obesity-related comorbidities.
Methods
A meta-analysis of studies that assessed AT outcomes was conducted through December 2018. Primary outcomes were changes in comorbidities at 1 year following AT. Secondary outcomes were the amount of weight loss at up to 4 years and pooled serious adverse events (SAEs).
Results
Five studies with 590 patients were included. At 1 year, there were improvements in metabolic conditions: mean difference (MD) in systolic blood pressure: -7.8 (-10.7 – -4.9) mm Hg; MD in diastolic blood pressure: -5.1 (-7.0 – 3.2) mm Hg; MD in triglycerides: -15.8 (-24.0 – -7.6) mg/dL; MD in high-density lipoprotein: 3.6 (0.7–6.6) mg/dL; MD in hemoglobin A1c (HbA1c): -1.3 (-1.8 – -0.8) %; MD in aspartate transaminase: -2.7 (-4.1 – -1.3) U/L; MD in alanine transaminase: -7.5 (-9.8 – -5.2) U/L. At 1 (n=218), 2 (n=125), 3 (n=46), and 4 (n=27) years, the patients experienced 17.8%, 18.3%, 19.1%, and 18.6% total weight loss (TWL), corresponding to 46.3%, 46.2%, 48.0%, and 48.7% excess weight loss (EWL) (p<0.0001 for all). Subgroup analysis of 2 randomized controlled trials (n=225) showed that AT patients lost more weight than did controls by 11.6 (6.5–16.7) %TWL and 25.6 (16.0–35.3) %EWL and experienced greater improvement in HbA1c and alanine transaminase by 1.3 (0.8–1.8) % and 9.0 (3.9–14.0) U/L. The pooled SAE rate was 4.1%.
Conclusions
Obesity-related comorbidities significantly improved at 1 year following AT. Additionally, a subgroup of patients who continued to use AT appeared to experience significant weight loss that persisted up to at least 4 years.
-
Citations
Citations to this article as recorded by  - Update on Endoscopic Treatments for Obesity
Fernanda Pessorrusso, Sagar V. Mehta, Shelby Sullivan
Current Obesity Reports.2024; 13(2): 364. CrossRef - Role of endoscopic duodenojejunal bypass liner in obesity management and glycemic control
Willian Ferreira Igi, Victor Lira de Oliveira, Ayah Matar, Diogo Turiani Hourneaux de Moura
Clinical Endoscopy.2024; 57(3): 309. CrossRef - Endobariatric systems: Strategic integration of endoscopic therapies in the management of obesity
Najib Nassani, Fateh Bazerbachi, Barham K. Abu Dayyeh
Indian Journal of Gastroenterology.2024; 43(5): 916. CrossRef - Advances in Endoscopic Bariatric and Metabolic Therapies
Reem H. Matar, Barham K. Abu Dayyeh
Gastroenterology Clinics of North America.2024; 53(4): 731. CrossRef - Endoscopic bariatric and metabolic therapies and its effect on metabolic dysfunction-associated steatotic liver disease: a review of the current literature
Varun Aitharaju, Jonathan Ragheb, Stephen Firkins, Roma Patel, C. Roberto Simons-Linares
Surgery for Obesity and Related Diseases.2024;[Epub] CrossRef - The evolution and current state of bariatric endoscopy in Western countries
Maria Valeria Matteo, Vincenzo Bove, Valerio Pontecorvi, Loredana Gualtieri, Giorgio Carlino, Cristiano Spada, Ivo Boškoski
Clinical Endoscopy.2024; 57(6): 711. CrossRef - Updates in Endoscopic Bariatric and Metabolic Therapies
Hammad Qureshi, Naba Saeed, Manol Jovani
Journal of Clinical Medicine.2023; 12(3): 1126. CrossRef - The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Aaron Yeoh, Robert Wong, Ashwani K. Singal
Clinics in Liver Disease.2023; 27(2): 413. CrossRef - Obesity management for cardiovascular disease prevention
Rama Hritani, Mahmoud Al Rifai, Anurag Mehta, Charles German
Obesity Pillars.2023; 7: 100069. CrossRef - Overview on the endoscopic treatment for obesity: A review
Maheeba Abdulla, Nafeesa Mohammed, Jehad AlQamish
World Journal of Gastroenterology.2023; 29(40): 5526. CrossRef - Endoscopic removal of a weight-loss device with stoma closure using a tack-and-suture device
Areebah Waseem, Joseph Wawrzynski, Daniel B. Maselli, Ashley Kucera, Chase Wooley, Christopher McGowan
VideoGIE.2023; 8(11): 441. CrossRef - Effect of Endoscopic Bariatric and Metabolic Therapies on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis
Pichamol Jirapinyo, Thomas R. McCarty, Russell D. Dolan, Raj Shah, Christopher C. Thompson
Clinical Gastroenterology and Hepatology.2022; 20(3): 511. CrossRef - Endobariatrics: well past infancy and maturing rapidly
Shreesh Shrestha, Esha Shrestha, Tilak Shah
Current Opinion in Gastroenterology.2022; 38(6): 592. CrossRef - Advances in endobariatrics: past, present, and future
Abhishek Shenoy, Allison R Schulman
Gastroenterology Report.2022;[Epub] CrossRef - Various Novel and Emerging Technologies in Endoscopic Bariatric and Metabolic Treatments
Hee Kyong Na, Diogo Turiani Hourneaux De Moura
Clinical Endoscopy.2021; 54(1): 25. CrossRef - Endoscopic Sleeve Gastroplasty (ESG) for High-Risk Patients, High Body Mass Index (> 50 kg/m2) Patients, and Contraindication to Abdominal Surgery
Renjie Li, Wilfried Veltzke-Schlieker, Andreas Adler, Maximilian Specht, Wael Eskander, Mahmoud Ismail, Harun Badakhshi, Manoel Passos Galvao, Ricardo Zorron
Obesity Surgery.2021; 31(8): 3400. CrossRef - Obesity Primer for the Practicing Gastroenterologist
Pichamol Jirapinyo, Christopher C. Thompson
American Journal of Gastroenterology.2021; 116(5): 918. CrossRef - Bariatric and metabolic endoscopy: impact on obesity and related comorbidities
Amit Mehta, Reem Z. Sharaiha
Therapeutic Advances in Gastrointestinal Endoscopy.2021;[Epub] CrossRef - Advanced endoscopic gastrointestinal techniques for the bariatric patient: implications for the anesthesia provider
Andrew Kim, Joshua A. Spiro, Thomas J. Hatzidais, Norman D. Randolph, Rosie Q. Li, Diana Ayubcha, Mark S. Weiss
Current Opinion in Anaesthesiology.2021; 34(4): 490. CrossRef - Preparing for the NASH Epidemic: A Call to Action
Fasiha Kanwal, Jay H. Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Gastroenterology.2021; 161(3): 1030. CrossRef - Preparing for the NASH epidemic: A call to action
Fasiha Kanwal, Jay H. Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Metabolism.2021; 122: 154822. CrossRef - Preparing for the NASH epidemic: A call to action
Fasiha Kanwal, Jay H. Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, Hashem El‐Serag, Kenneth Cusi
Obesity.2021; 29(9): 1401. CrossRef - Preparing for the NASH Epidemic: A Call to Action
Fasiha Kanwal, Jay H. Shubrook, Zobair Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E. Rinella, Stephen A. Harrison, Christos Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H. Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Diabetes Care.2021; 44(9): 2162. CrossRef - Endobariatrics and Metabolic Endoscopy: Can We Solve the Obesity Epidemic with Our Scope?
Jad Farha, Shahem Abbarh, Zadid Haq, Mohamad I. Itani, Andreas Oberbach, Vivek Kumbhari, Dilhana Badurdeen
Current Gastroenterology Reports.2020;[Epub] CrossRef
-
6,303
View
-
145
Download
-
21
Web of Science
-
24
Crossref
|
KSGE
